Double-blind controlled trial of amylopectin sulphate (Depepsen) in the symptomatic treatment of duodenal ulcer.
- 1 September 1977
- Vol. 18 (9) , 723-724
- https://doi.org/10.1136/gut.18.9.723
Abstract
In a double-blind controlled trial amylopectin sulfate (Depepsen) had no significant advantage over placebo in the symptomatic treatment of duodenal ulcer [human].This publication has 9 references indexed in Scilit:
- A controlled trial of antacid, propantheline and amylopectin sulfate in duodenal ulcer.1973
- A Trial of Amylopectin Sulfate (SN-263) and Propantheline Bromide in the Long Term Treatment of Chronic Duodenal UlcerGastroenterology, 1972
- A Controlled Study on the Use of Propantheline and Amylopectin Sulfate (SN-263) for Recurrences in Duodenal UlcerGastroenterology, 1970
- Specific Inhibition of Gastric Pepsin in the Treatment of Gastric UlcerGastroenterology, 1969
- EFFECT OF A SYNTHETIC SULFATED POLYSACCHARIDE (SN-263) ON GASTRIC PEPTIC ACTIVITY IN HUMANSAnnals of the New York Academy of Sciences, 1967
- EFFECT OF DEPEPSEN IN THE TREATMENT OF PEPTIC ULCERAnnals of the New York Academy of Sciences, 1967